Rep. John Shimkus was recently honored at a breakfast sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA). The PhRMA honored Shimkus for leading an effort to block a program that would reduce the costs of the Medicare Part B program. Shimkus obtained the signatures of 242 legislators in the House and introduced legislation to stop this program.
How can Shimkus justify his efforts to block lowering drug prices for seniors? He received $300,000 from the pharmaceutical industry this last election cycle. Perhaps he chose to sacrifice lower drug costs as to not disappoint the industry that significantly contributed to his campaign. Simply put, the pharmaceutical industry bought Shimkus’ efforts and honored him when he proved successful. His efforts saved the pharmaceutical companies billions of dollars at the expense of seniors on Medicare.
Another reason Shimkus avidly supported the AHCA is also tied to his receipt of PhRMA contributions. The pharmaceutical manufacturers, importers, distributors, and retailers were ecstatic when House Republicans passed the AHCA because there was absolutely nothing in the bill to control drug costs. Further, the bill would repeal a fee on manufacturers and importers that would save these manufacturers over $2.5 billion a year.
Rep. Shimkus consistently votes with big business and against the middle class. I will not be owned by special interests. My votes cannot be bought and will always benefit the constituents I will be representing.
I’m Carl Spoerer and I’m running for Congressman of the Illinois 15th District.
Carl Spoerer, Mahomet